Systemic inflammation has been identified as a risk factor for the development of heart failure in population studies. In the 5-year prospective MESA study, researchers from Johns Hopkins Hospital in Baltimore recorded a baseline nonspecific marker of systemic inflammation, C-reactive protein (CRP).
Systemic inflammation has been identified as a risk factor for the development of heart failure in population studies. In the 5-year prospective MESA study, researchers from Johns Hopkins Hospital in Baltimore recorded a baseline nonspecific marker of systemic inflammation, C-reactive protein (CRP). After controlling for usual coronary and CHF risk factors, including diabetes, coronary disease, hypertension, smoking status, and BMI, a positive correlation between CRP and myocardial functional deterioration on echocardiogram is observed over the follow-up period. CRP is an independent risk factor for myocardial deterioration.
Choi EY et al. High sensitivity C-reactive protein as an independent predictor of progressive myocardial functional deterioration: the longitudinal multi-ethnic study of atherosclerosis (MESA). Johns Hopkins Hospital, Baltimore. Presented at: ACC 2011; April 3, 2011; New Orleans.
For additional coverage of ACC 2011 >>
FDA Proposed Rule Would Limit Nicotine Content in Cigarettes, Cigars, Other Combusted Products
January 16th 2025The agency estimates that limiting nicotine levels could lead to 1.8 million fewer tobacco-related deaths by 2060 and health care savings of $1.1 trillion a year over the next 40 years.